Survey on the use of cardiac markers in Italy;Indagine sull'utilizzo dei marcatori miocardici in Italia

Rivista Italiana della Medicina di Laboratorio

Volumn 1, Issue 1, 2005, Pages 44-53

  Galli, Gianni A ^a,d   Gambetta, Claudio ^b   Caputo, Marco ^c   Cappelletti, Piero ^a  

^a DML   (Italy)

^b ASL RM E   (Italy)

^c Laboratorio Patologia Clinica   (Italy)

^d Unità Dipartimentale Medicina di Laboratorio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; TROPONIN;

HEALTH SURVEY; HEART MUSCLE NECROSIS; HUMAN; ITALY; POINT OF CARE TESTING; QUESTIONNAIRE; REVIEW;

EID: 33747748183     PISSN: 1825859X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Alpert JS, Thygensen K, Antman E, Bassand JP. Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959-69.
2. Braunwald E, Antman EM, Beasly JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) J Am Coll Cardiol 2000; 36:970-1062.
3. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MH, Waldes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice. Recommendations for the use of cardiac markers in coronary artery disease. Clin Chem 1999; 45:1104-21.
4. Wu AHB. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Sub-committee on Standardization of Cardiac Markers (S-SCM). Scand J Clin Lab Invest Suppl 1999; 230:74-82.
5. Apple FS, Murakami M, Panteghini M, Christenson RH, Dati F, Mair J, et al. International survey of cardiac troponin users. Clin Chem 2001; 47:587-9.
6. Jernberg T, Lindahl B, Wallentin L. Uniform diagnosis of myocardial infarction. Rapid development at Swedish hospitals. Lakartidningen 1998; 95:515-20.
7. Tsang WM, Owen AM, Collinson PO, Barth JH. Surveys on the use of cardiac markers in the UK. Ann Clin Biochem 2003; 40:138-42.
8. Bardaji A, Bueno H, Fernandez-Ortiz A, Heras M. Applicability of a new definition of myocardial infarction and the opinion of Spanish cardiologists. Rev Esp Cardiol 2003; 56:23-8.
9. Hasdaia D, Beharb S, Boykob V, Danchinc N, Bassand JP, Battler A. Cardiac biomarkers and acute coronary syndromes - The Euro Heart Survey of Acute Coronary Syndromes Experience. Eur Heart J 2003; 24:1189-94.
10. Di Pasquale G, Lombardi A, Casella G. The redefinition of acute myocardial infarction. Ital Heart J 2004; 5:9S-18S.
11. Ottani F, Galvani M, Dolci A, Plebani M, Tubaro M, Zaninotto M, et al.; Gruppo di Studio Interdisciplinare Intersocietario ANMCO-SIBioC-SIMeL. I marcatori di danno miocardico nella diagnosi di infarto miocardico acuto: la realtà italiana nell'anno 2000. Ital Heart J Suppl 2002; 3:933-42.
12. Sciacovelli L, Zardo L, Secchiero S, Zaninotto M, Plebani M. Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness. Clin Chim Acta 2003; 333:209-19.
13. NACB LMPG Evidence Based Practice for POCT. http://www.nacb.org/lmpg/ main.stm (ultima consultazione 13 aprile 2005)
14. Novis DA, Jones BA, Dale JC, Walsh K; College of American Pathologists. Biochemical markers of myocardial injury test turnaround time: a College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions. Arch Pathol Lab Med. 2004; 128:158-64.
15. Sheehan P, Blennerhassett J, Vasikaran SD. Decision limit for troponin I and assay performance. Ann Clin Biochem 2002; 39:231-6.
16. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004; 50:327-32.
17. Ming S, Krishnaswamy P, Morrisey R, Clopton P, Fitsgerald R, Maisel AS. Mitigations of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J Cardiol 2001; 87:994-9.